STEPHANIE CASTEEL: Open Payments
NPI 1326610452 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 24 payments from 9 companies in 2025. Trend: 2023 $146 · 2024 $948 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Zynex Medical, Inc. | 1 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Lilly USA, LLC | 4 | $88 |
| Novo Nordisk Inc | 3 | $66 |
| Corcept Therapeutics | 3 | $61 |
| Viatris Specialty LLC | 2 | $61 |
| ABBVIE INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Nexwave, XIFAXAN, TRELEGY ELLIPTA, MOUNJARO, Korlym, YUPELRI, Rybelsus, MAVYRET.
Industry payments across CA — which companies pay providers there.
